Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding trial of Xiao'er Qingzhen oral liquid in children with early hand-foot-and-mouth disease
ChiCTR1900028384Phase 2Not yet recruiting
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Xiaoer Qingzhen Oral Liquid in hand, foot, and mouth disease (HFMD) (3 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoint: Time to resolution of fever. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
Xiaoer Qingzhen Oral Liquid
03
Conditions
hand, foot, and mouth disease (HFMD)
Beyond the preview
Go deeper on ChiCTR1900028384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900028384.